What FDA has said recently (high-level, patient-friendly summary) FDA maintains a page describing certain bulk drug substances used in compounding that may present significant safety risks, including AOD-9604, noting concerns such as potential immunogenicity and limited safety-related information for some uses/routes
Health Canada has not approved BPC-157 as a health product, and the compound exists in a legal gray area in Canada
Shaking can cause the delicate peptide chains to break apart or denature, which may render the compound ineffective
Track waist measurements and how clothes fit alongside any scale weight
Most available products are marketed as research chemicals or for laboratory use only. This creates significant and very real risks: Contamination and impurity : Products from unverified vendors may contain impurities, incorrect concentrations, or even entirely different compounds than whats advertised on the label
Book your session today and start your journey to renewed vitality